Concepedia

Masato Kaneko

MK

6

Publications

301

Citations

6

H-Index

1999

Active since

Affiliations

Bayer (Japan)(Current)

Bayer (Germany)

Bayer (United States)

Masato Kaneko is an author at Bayer (Japan) specializing in medicine, pharmacology, and statistical genetics.

Top concepts

Publications per year

1999–2017

6

Publications

6

Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation

Takahiko Tanigawa, Masato Kaneko, Kensei Hashizume et al. · Drug Metabolism and Pharmacokinetics · 2012 · 102 citations

Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases

Keisuke Yoshida, Tomohiro Kaneta, Shoko Takano et al. · Annals of Nuclear Medicine · 2016 · 61 citations · Full text

Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients

Masato Kaneko, Takahiko Tanigawa, Kensei Hashizume et al. · Drug Metabolism and Pharmacokinetics · 2013 · 56 citations

A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

Toshihiko Doi, Nozomu Fuse, Takayuki Yoshino et al. · Cancer Chemotherapy and Pharmacology · 2016 · 37 citations · Full text

Intracerebroventricular administration of nocistatin reduces inflammatory hyperalgesia in rats

Takayuki Nakagawa, Masato Kaneko, Shogo Inamura et al. · Neuroscience Letters · 1999 · 32 citations

, , +8

Rows per page

1–5 of 6